.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Federal Trade Commission
Cerilliant
Boehringer Ingelheim
Teva
McKinsey
Merck
QuintilesIMS
Accenture
Farmers Insurance

Generated: June 25, 2017

DrugPatentWatch Database Preview

ENDURONYL FORTE Drug Profile

« Back to Dashboard

What is the patent landscape for Enduronyl Forte, and what generic Enduronyl Forte alternatives are available?

Enduronyl Forte is a drug marketed by Abbott and is included in one NDA.

The generic ingredient in ENDURONYL FORTE is deserpidine; methyclothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; methyclothiazide profile page.

Summary for Tradename: ENDURONYL FORTE

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list50
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ENDURONYL FORTE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott
ENDURONYL FORTE
deserpidine; methyclothiazide
TABLET;ORAL012775-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Farmers Insurance
Moodys
Colorcon
Chubb
Johnson and Johnson
Teva
Merck
Fuji
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot